← Back
$GLUE All transactions

Monte Rosa Therapeutics, Inc.

A

$ Value

$0

Shares

406,000

Price

$0

Filed

Jan 5

Insider

Name

Warmuth Markus

Title

President & CEO

CIK

0001855643

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

406,000

Footnotes

Represents restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 25% of the RSUs shall vest on January 2, 2027, with the remainder vesting in 3 equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date. | Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.17 to $15.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | 25% of this option shall vest and become exercisable on January 2, 2027, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Filing Info

Accession No.

0001193125-26-002389

Form Type

4

Issuer CIK

0001826457

Warmuth Markus's History

Date Ticker Type Value
2026-04-14 GLUE $141K
2026-03-02 GLUE $98K
2026-01-07 GLUE $86K
2026-01-07 GLUE $35K
2026-01-07 GLUE $8K
2026-01-05 GLUE $154K
2026-01-02 GLUE A
2026-01-02 GLUE A $0

Other Insiders at GLUE (90d)

Insider Bought Sold Last
Warmuth Markus
President & CEO
$239K 2026-04-14
Janku Filip
Chief Medical Officer
$179K 2026-02-23
Nickson Philip
Chief Business & Legal Officer
$103K 2026-04-09
Dunn Edmund
Principal Accounting Officer
$467K 2026-03-04
Bowen Matthew
Principal Accounting Officer
2026-04-06